Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management

NCT02199236 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Rectal or Anal Cancer

Interventions

RADIATION: endorectal brachytherapy
DRUG: concurrent capecitabine or 5-FU
BEHAVIORAL: Questionnaires

Sponsor

Memorial Sloan Kettering Cancer Center